POSVAX
Posvax develops prophylactic vaccines for life cycle-related diseases affecting the elderly. The company operates a biopharmaceutical company that develops vaccines and anticancer drugs.
POSVAX
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.posvax.com
Status:
Active
Contact:
+82-70-5220-0215
Email Addresses:
[email protected]
Technology used in webpage:
South Korean Server Location
Similar Organizations
Ailomics Therapeutics
Ailomics Therapeutics focuses on developing innovative drugs to treat immune diseases and tumors.
Haldane Pharmaceuticals
Haldane Pharmaceuticals develops and markets innovative pharma products and offers access at an affordable cost with great value.
Immunitor
Immunitor develops orally-delivered immunotherapies for a number of serious diseases affecting the world.
Palladio Biosciences
Palladio Biosciences develops transformative medicines for orphan diseases of the kidney.
SymBio Pharmaceuticals
SymBio Pharmaceuticals develops therapeutic products for cancer, hematology, and autoimmune diseases.
Yuntao Biotechnology
Yuntao Biotechnology focuses on research and development, production and sales of pharmaceutical intermediates and other fine chemicals.
Current Employees Featured
Founder
Investors List
HB Investment
HB Investment investment in Venture Round - Posvax
Official Site Inspections
http://www.posvax.com
- Host name: 203.245.44.67
- IP address: 203.245.44.67
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Posvax"
POSVAX
The researchers in POSVAX have established the technology to select the perfect form of virus-like particles based on protein structure analysis and immunological researches for the last 15 …See details»
POSVAX - 2025 Company Profile, Team & Funding - Tracxn
May 11, 2025 Explore POSVAX's in-depth company profile, including funding details, key investors, and leadership.See details»
Jobs at PopVax
PopVax is hiring aggressively for scientific, manufacturing, legal, and communications roles as we build out a novel mRNA vaccine and therapeutics platform.See details»
Posvax - Crunchbase Company Profile & Funding
Posvax develops prophylactic vaccines for life cycle-related diseases affecting the elderly.See details»
POSVAX 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for POSVAX. Use the PitchBook Platform to explore the full profile.See details»
PopVax: mRNA vaccines and therapeutics using computational …
Our experimental work is based at the RNA Foundry, PopVax’s integrated R&D and GMP-capable clinical dose production facility in Hyderabad. Our work to date has been funded primarily via …See details»
PopVax is Awarded 2 Million USD as One of the Winners of the …
Jan 14, 2025 PopVax’s work has been funded in part via project agreements with the Bill & Melinda Gates Foundation and with Balvi, a global health and biosecurity organization started …See details»
PopVax Information - RocketReach
Our experimental work is based at the RNA Foundry, PopVax’s integrated R&D and GMP-capable clinical dose production facility in Hyderabad. Our work to date has been funded primarily via …See details»
POSVAX
Virus-like particle (VLP) platform technology is an emerging technology maximizing values of bio-pharmaceuticals including vaccines and anticancer drugs. POSVAX Co., LTD was established in 2018, we are “Bio …See details»
About - The PopVax Chronicles
What it takes to develop, manufacture, test, and deploy broadly-protective mRNA vaccines. Click to read The PopVax Chronicles, a Substack publication with hundreds of subscribers.See details»
PopVax - Crunchbase Company Profile & Funding
PopVax an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics.See details»
PopVax Overview | SignalHire Company Profile
PopVax is an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using computational protein design. Our first vaccine is a next-generation COVID …See details»
PopVax Announces that the U.S. National Institute of Allergy and ...
Nov 14, 2024 MUMBAI, India & HYDERABAD, India – Business Wire India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using …See details»
How a new global vaccine stockpile will help to counter the …
2 days ago A year after the World Health Organization (WHO) declared mpox a public health emergency of international concern (PHEIC), the virus has spread rapidly across Africa, and …See details»
How do you make a 250x better vaccine at 1/10 the cost? Develop …
Feb 3, 2025 This story is still being written, but there's good reason to be bullish, given that PopVax has an (in mouse) influenza vaccine that is 250x better than its competitors, multiple …See details»
Molecular and Cell Biologist at PopVax
Dec 31, 2024 Our work to date has been funded primarily via project agreements totalling 10+ million USD with the Bill & Melinda Gates Foundation and Vitalik Buterin's public health & …See details»
PopVax updates – NIH NIAID will conduct the Phase I trial for our …
Dec 22, 2024 As part of this initiative, the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), will conduct and sponsor the …See details»
Executive – Manufacturing Quality Compliance at PopVax
Mar 18, 2025 Our work to date has been funded primarily via project agreements totalling 10+ million USD with the Bill & Melinda Gates Foundation and Vitalik Buterin's public health & …See details»
The unlikely, inevitable founding of PopVax, Part I: Three meetings …
Nevertheless, PopVax’s 50-person operation has quickly become one of the leading centres of vaccine research and development in the country, working at the frontier of translational biology.See details»
Molecular and Cell Biologist - Weekend/Evening Shift at PopVax
Dec 10, 2024 Our work to date has been funded primarily via project agreements totalling 10+ million USD with the Bill & Melinda Gates Foundation and Vitalik Buterin's public health & …See details»